» Articles » PMID: 16791471

Expression of SOX9 and SOX10 in Central Neuroepithelial Tumor

Overview
Journal J Neurooncol
Publisher Springer
Date 2006 Jun 23
PMID 16791471
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The SOX group E transcription factors play an integral role in the specification and differentiation of astrocytes and oligodendrocytes. We have examined the pattern of expression for SOX9 and SOX10 in primary brain tumors by immunohistochemistry. Pediatric and adult high grade tumors display strong nuclear staining for both SOX9 and SOX10 (astrocytic, oligodendroglial and primitive neuroectodermal tumors). In comparison pediatric pilocytic astrocytoma express much less SOX9 and SOX10. Reactive astrogliosis is characterized by an increase of SOX9 only.

Citing Articles

Increased SOX10, p16, and Cyclin D1 Immunoreactivity Differentiates MAP Kinase-activated Low-grade Gliomas From Piloid Gliosis.

Tang V, Zhang K, Mirchia K, Lu R, Guney E, Terry M Am J Surg Pathol. 2025; .

PMID: 39807609 PMC: 11892991. DOI: 10.1097/PAS.0000000000002353.


Adult cerebellar glioblastoma categorized into a pediatric methylation class with a unique radiological and histological appearance: illustrative case.

Ono T, Hinz F, Tanaka S, Takahashi M, Nanjo H, von Deimling A J Neurosurg Case Lessons. 2022; 3(14).

PMID: 36303507 PMC: 9379691. DOI: 10.3171/CASE2260.


Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma.

Khashkhashi Moghadam S, Bakhshinejad B, Khalafizadeh A, Hussen B, Babashah S J Cell Mol Med. 2021; 26(2):287-305.

PMID: 34907642 PMC: 8743668. DOI: 10.1111/jcmm.17126.


SOX9: Advances in Gynecological Malignancies.

Chen H, He Y, Wen X, Shao S, Liu Y, Wang J Front Oncol. 2021; 11:768264.

PMID: 34881182 PMC: 8645898. DOI: 10.3389/fonc.2021.768264.


Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation.

Korshunov A, Okonechnikov K, Schmitt-Hoffner F, Ryzhova M, Sahm F, Stichel D Acta Neuropathol Commun. 2021; 9(1):20.

PMID: 33536079 PMC: 7860633. DOI: 10.1186/s40478-021-01118-5.


References
1.
Stolt C, Schmitt S, Lommes P, Sock E, Wegner M . Impact of transcription factor Sox8 on oligodendrocyte specification in the mouse embryonic spinal cord. Dev Biol. 2005; 281(2):309-17. DOI: 10.1016/j.ydbio.2005.03.010. View

2.
Johansson F, Goransson H, Westermark B . Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice. Oncogene. 2005; 24(24):3896-905. DOI: 10.1038/sj.onc.1208553. View

3.
Bannykh S, Stolt C, Kim J, Perry A, Wegner M . Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas. J Neurooncol. 2005; 76(2):115-27. DOI: 10.1007/s11060-005-5533-x. View

4.
Stolt C, Lommes P, Sock E, Chaboissier M, Schedl A, Wegner M . The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev. 2003; 17(13):1677-89. PMC: 196138. DOI: 10.1101/gad.259003. View

5.
Gershon T, Oppenheimer O, Chin S, Gerald W . Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation. Neoplasia. 2005; 7(6):575-84. PMC: 1501286. DOI: 10.1593/neo.04637. View